Literature DB >> 4174157

Isoprenaline resistance and the use of pressurised aerosols in asthma.

J W Paterson, M E Conolly, D S Davies, C T Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4174157     DOI: 10.1016/s0140-6736(68)90467-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

1.  Absorption of drugs by the lung.

Authors:  G M Shenfield; M E Evans; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

3.  Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Authors:  H Minatoya; B A Spilker
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

4.  Editorial: Bronchodilators, new and old.

Authors: 
Journal:  Br Med J       Date:  1976-08-14

5.  Investigation into isoprenaline resistance in patients with obstructive lung disease.

Authors:  A Lichterfeld; H Löllgen
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

6.  Resistance to beta-adrenoceptor stimulants.

Authors: 
Journal:  Br Med J       Date:  1972-01-15

7.  Proceedings: The effect of methoxy-derivatives of catecholamines on histamine release from sensitized human leucocytes and its inhibition by the parent compounds.

Authors:  E S Assem
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

Review 8.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Beta-adrenoceptor antagonist activity of 3-methoxyisoprenaline.

Authors:  J R Bassett
Journal:  Br J Pharmacol       Date:  1971-01       Impact factor: 8.739

10.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.